CA$ 5.41
Key Takeaways
Risk factor
Poor trading liquidity
Profitability factor
Favourable analyst view
About
kneat.com, inc. designs, develops, and supplies software for data and document management within regulated environments in the United States, Ireland, Canada, and internationally. The company offers Kneat Gx platform, a configurable commercial off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. Its platform is used in process,...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.
Target Price
The average target price of KSI.TO is 7.5 and suggests 39% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
